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Antigen activation ofmature T cells results in synthesis and secretion ofIL-2 and
surface expression of functional IL-2 receptors (IL-2-R) . Subsequent binding and
endocytosis of IL-2 leads to T cell growth (1, 2) . IL-2-R. have also been found on
a high proportion of the small subset ofCD4-,CD8- adult thymocytes and on day
14-16 fetal CD4-,CD8- thymocytes in mice (3-8) . These CD4-,CD8- thymocytes
have the properties of intrathymic "stem cells," in that they are the first to appear
in the embryonic thymus (9), and contain the precursors to all major T cell subsets
(10) . The presence ofIL-2-R on intrathymic precursors has led to the speculation
that the IL-2-IL-2-R pathway might be involved in the proliferation and/or differen-
tiation ofT cells . However, the physiological relevance of IL-2-R expression by
CD4-,CD8- thymocytes is unclear, as the receptors appear to be nonfunctional :
freshly isolated CD4-,CD8- adult or fetal thymocytes do not respond to IL-2 (4,
6-8), and express only low affinity IL-2-R (3, 8) . To test the hypothesis that the IL-2-
IL-2-R pathway plays a role in intrathymic fetal T cell development, we attempted
to block signaling via IL-2-R occupancy in the fetal thymus by treating pregnant
mice with mAbs to the IL-2-R . The results demonstrate that thymocytes from new-
born mice born to anti-IL-2-R antibody-treated mothers do not contain mature
CD4+ or C138+ single-positive T cells, which suggests that IL-2-IL-2-R interac-
tions provide signals crucial to in vivo intrathymic development of T cells .
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Materials and Methods
Mice and mAb Treatments.
￿
Timed pregnant C57 BL/6 mice were treated daily from day
12 of pregnancy with 2 mg each of the monoclonal rat anti-mouse IL-2-R mAbs 3C7 and
2E4 or3C7 and 7134 (11) . Purified antibodies were prepared from ascites, and antibody injec-
tions were given intraperitoneally . Control mice received daily injections of purified rat IgG
or saline, once it was established that purified rat IgG had no effect .
Flow Cytometry Analysis.
￿
Thymocyte suspensions from fetal or newborn mice were pre-
pared in HBSS without phenol red containing 0.1% BSA and 0.1% sodium azide . Staining
and washing procedures were as described (10) . Flow cytometry analysis was performed on
a dual laser FRCS II (B-D Automated Immunochemistry Salt Lake City, UT) interfaced
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to a PDP 11/24 computer (Digital Equipment Corp ., Maynard, MA) . Data were collected
on 50,000 viable cells, as determined by forward light scatter and propidium iodide gating.
For IL-2-R analysis, cells were reacted either with a combination of FITC-labeled mouse
mAb to rat-7c chain (B-D Automated Immunochemistry) and FITC-labeled goat anti-rat
IgG (Kirkegaard& Perry Laboratories, Gaithersburg, MD), or with 3C7 plus 2E4, followed
by the FITC-anti-rat IgG reagents . For CD8/CD4 and CD5/CD8 analysis (10), cells were
reacted with FITC-conjugated anti-CD8 mAb (B-D Automated Immunochemistry) followed
by biotin-conjugated anti-CD4 mAb, followed by Texas Red streptavidin (TRA) (Bethesda
Research Laboratories, Bethesda, MD), or by FITC-conjugated anti-CD5 mAb, followed
by biotin-conjugated anti-CD8 mAb and TRA . For Vp8 analysis, cells were reacted with
the Vp8 chain-specific mAb F23 .1 (12), followed by FITC-anti-mouse IgG2a, or with
FITC-anti-mouse IgG2a alone .
Limiting Dilution Microculture Techniques.
￿
Thymocytes from newborn mice were tested for
frequency of IL-2-producing cells andCTL precursor cells (9, 13) . For IL-2 precursor assays,
supernatants of microtiter wells were tested after 6 d for their ability to support proliferation
of CTLL cells . For CTL precursor assays, 10 3 "Cr-labeled P815 (H-2d) target cells were
added per well after 7 d ; radioactivity in the supernatants was measured after 6 h at 37°C .
Results and Discussion
Fetal thymocytes from anti-IL-2-RmAb-treated pregnant mice bore the injected
rat mAb on their surface. Fig. 1 shows that fetal day 17 thymocytes from treated
mice exhibited only slightly more fluorescence when stained with 3C7 + 7D4 mAb
followed by FITC-conjugated anti-rat Ig, than when stained with FITC-conjugated
anti-rat Ig alone . All the rat mAb was contained within the subpopulation of dull-
CD5-expressing cells (data not shown), consistent with the notion that the mAb
bound to CD4-,CD8- cells . Similar results were obtained at earlier time points of
embryonic development, i.e ., from day 13 on ; even at day 20 (the time of birth),
the small number of IL-2-R-bearing cells was unchanged, albeit all IL-2-11 was still
blocked with rat rnAb (data not shown) . These findings not only demonstrate that
the IL-2-R can be saturated with mAb in the fetal thymus, but, even more impor-
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￿
Single-color fluorescence flow cytometry (FCM) analysis of IL-2-R expression on
day 17 fetal thymocytes from control (left) and anti-IL-2-R-treated (right) pregnant mothers. Timed
pregnant C57BI/6 mice were treated with a combination of rat anti-IL-2-R mAbs (3C7 plus
2E4 [11, 12]) purified from ascites . Intraperitoneal injections of2 mg of each antibody were given
daily from day 12 of pregnancy until the day of the experiment . Data are representative of five
separate experiments . The percent ofIL-2-R' cells was 37 .3 ± 4.1% in the control group, and
the percent of rat IgG' cells was 36 .5 ± 3.9% in the treated group . Each histogram shows
staining for FITC-anti-rat IgG (---) or staining with 3C7 plus 2E4, followed by FITC-anti-rat
IgG (-) .tantly, that the IL-2-R-bearing cells were not eliminated by theantibody treatment.
This is specifically relevant (see below) in view of the recent finding (14) that IL-
2-R+ thymocytes contain precursors for mature CD4 and CD8 single-positive T
cells.
When thymocytes from newborns were examined forCD4, CD8, and CD5 (Ly-1)
expression, significant differences were noted between those from control and anti-
IL-2-R-treated mothers. Fig. 2, left, showsthat thenumbersofCD4 andCD8 single-
positive cells are reduced in the thymus from mice born to treated mothers. This
absence of T cells with a mature phenotype was confirmed by demonstrating ab-
sence of the bright CD5+ (Ly-lhi) CD8- subset (Fig. 2, right), corresponding mostly
to CD4+,CD8" cells (10), and absence of the bright CD5+,CD4- subset (data not
shown), corresponding to CD4-,CD8+ cells (10). In addition, the number of
CD4-,CD8- cells in the thymus from treated mice has increased (Fig. 2, left), but
no change in the percentage of CD4+,CD8+ double-positive cells occurred. Post-
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FIGURE 2.
￿
Two-colorFCM analysis of cell surface CD4 andCD8 expression (left) or CD5 and
CD8expression (right) on thymocytes ofnewborn babies born to control(top) andanti-IL-R-treated
(bottom) mothers. Pregnant mice were treated daily as indicated in Fig. 1, until theday of birth.
Data aredisplayedas contourdiagrams,with athree-decade logscaleofincreasing greenfluores-
cence on the x-axis, andincreasing red fluorescence on they-axis. Thex andy coordinates that
defined negative cells were selected as the intersection of positive and control negative profiles
in each parameter (i.e., obtained by staining with an irrelevant negative control mAb). Data are
representative for five separate experiments. In this representative experiment, the percent of
CD4' CD8- cells was 11.8% in control thymus, and 1.6 t 0.4% in treated thymus; the percent
of CD4-,CD8' cells was 1.8% in control thymus, and 0.3% in treated thymus; the percent of
bright CD5',CD8- was 10.5% in control thymus, and 1.4% in treated thymus.1744
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natal treatment with saturating doses of anti-IL-2-R antibody had no effect on
CD4/CD8 expression (data not shown ; five separate experiments in which effects
were monitored forup to3wk oflife) . Finally, the totalnumber ofthymocytes recov-
ered from control and antibody-treatedmotherswasnot different ; control mice con-
tained 10 .5 ± 2 .6 x 106 cells, and treated mice, 10.8 ± 3.2 x 106 (average of five
experiments), thus excluding general toxic effects of the antibody.
Theseresults raised the possibility that blocking of the IL-2-R in the fetalthymus
prevented generation of mature T cells . To further address this question, thymo-
cytes from control and experimental mice were tested forthe presence of functional
CD4+,CD8- andCD4-,CD8+ T cells by a sensitive limiting dilution culture system,
in which their ability to secrete IL-2 and generate CTL precursors in response to
MHC alloantigens was determined. FunctionalT cellsbegin to appeararound birth
(9), reflecting appearance of aTCRa/a heterodimer complex on single-positive cells
(15) . It canbe seen in Table I that thymocytes from babies born to anti-IL-2-R-treated
mothers are devoid of functional CD4 + and CD8+ T cells, in that their levels of
IL-2-producing precursors _and CTL precursors are below detection limits . That
this lack of responsiveness was not simply dueto carry-over ofblocking anti-IL-2-R
antibody into the cultures was deduced from the fact that control thymocytes prein-
cubated in anti-IL-2-R antibody in vitrodid not exhibit reducedprecursorfrequen-
cies (data not shown) . The spleens from both control and treated newborns did not
contain functional T cells (data not shown), excluding the possibility that the treat-
ment had resulted in accelerated migration of mature cells to the spleen . Thus, by
both phenotypical and functional criteria, anti-IL-2-R treatment of pregnant mice
results in profound depletion of mature functional CD4+,CD8 - and CD4-,CD8+
T cells in the fetal thymus .
TABLE I
Absence of Alloreactioe IL-2-producing Cells and CTL Precursors in
the Thymus from Anti-IL-2-R-treated Mice
Varying numbers of responder cells were cultured in 96-well round-bottomed
microtiter plates with 5 x 104 (1110 x B10.D2)FI nude peritoneal stimulator
cells for 5 d (IL-2 precursor assay), or with 5 x 105 (1110 x B10.D2)Ft nude
spleen cells and 10% delectinated rat Con A supernatant for 7 d (CTL precursor
assay) . Per responder cell doses, 36 replicate microcultures were used, and only
experiments in which a linear semilogarithmic relationship between the propor-
tion of negative cultures and the dose ofresponder cells was observed are shown .
Cultures were defined as positive when the radioactivity ([ 3H]TdR incorpo-
ration intoCTLL cells for IL-2 precursor assays ; 5ICr release forCTL precur-
sor assays) exceeded by >3 SD the mean radioactivity of control cultures
incubated with stimulator cells alone .
Exp .
C57B1/6
responder
thymus
Frequency
IL-2 producers CTL precursors
1 Control 1/840 1/4210
Anti-IL-2-R` <1/10 5 <1/105
2 Control 1/670 1/3530
Anti-IL-2-R <1/10 5 <1/105
3 Control 1/720 1/3960
Anti-IL-2-R <1/10 5 <1/105Our results suggest thatT cells capable of responding to stimulation through the
TCRa/D are not generated in the fetal thymus in the presence of anti-IL-2-R anti-
body. To more directly address this issue, we analyzed thymocytes ofnewbornmice
from treated and untreated mothers for surface expression ofTCR a chain . Since
no pan-anti-murineTCR 0 and a chain reagents are available that detect surface
protein, we used one of theTCR a chain allotype reagents . The TCRVD8-specific
mAb F23.1 (12) recognizes an epitope on the TCR of 20-2570 of both CD4+ and
CD8' peripheral T cells (12, 15) in mouse strains expressing the V08 gene segment .
The number of TCRVD8-expressing cells is fairly low in the thymus at birth (15),
and F23 .1 staining appears as adull shift in staining intensity on fluorescence histo-
grams (data not shown) . Nevertheless, thymocytes from newborn control mice ex-
hibit detectable numbers of V08-expressing cells when F23 .1 staining is plotted vs .
light scatter, while no such cells are present in babies from the anti-IL-2-R group
(Fig. 3) . All V08-expressing cells on the day of birth are present in the subsets ex-
pressing CD4 and/or CD8 and not amongCD4-,CD8- cells, in agreement with
recent findings (16) . However, since the total number ofV08-bearing cells in each
subset is on the limits of reliable detection (i.e ., between 0.2 and 1 .0 0 Io), and only
low levels ofF23.1 expression were found, no percentages ofV08-cells for each subset
can be given . Thesedata are consistent with theabsence ofV08-bearing cells among
thymocytes from anti-IL-2-R-treated babies . Moreover, since no alloantigen-specific
T cells were found in the thymus of these mice, these data, by inference, imply ab-
sence of all TCRa/R-bearing mature T cells in the thymus from treated mice .
There is controversy over the physiological role of the IL-2-R in fetalT cell devel-
opment. Previous studies have demonstrated that freshly isolated CD4-,CD8- , IL-
2-R' thymocytes proliferate only poorly in response to IL-2 (3, 4, 6-8), are in-
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￿
FCM analysis ofTCRVg8 expression by thymocytes from newborns of untreated
and in vivo anti-IL-2-R mAb-treated C57BL/6 pregnant mice. Pregnant mice were treated daily
from day 12 ofgestation with anti-IL-2-R mAbs . Data are displayed as a contour plot, in which
the log of fluorescence intensity (y-axis) is plotted against the light scatter (x-axis) . No staining
wasobtainedwhen control thymocytes were stained with FITC-labeled anti-mouse IgG2a alone
(data not shown) . The presence of rat IgG (i.e ., anti-IL-2-R antibody) does not interfere with
V08 staining (data not shown) . Two-color flow cytometry analysis of greenV08 staining in con-
trol mice vs. red CD4 or red CD8 staining revealed that, on the dayof birth, most Vp8' cells
were in the CD8' compartment, few in the CD4' compartment, and none in the CD4-,CD8-
compartment .1746
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capable of internalizing IL-2 (8), and express only low affinity IL-2-R (3, 8) . Yet,
it is clear that CD4 -,CD8 - fetal thymocytes have the ability to produce IL-2 (7, 17) .
In addition, it is possible to induce high affinity IL-2-R on CD4-,CD8- thymocytes
upon activation in vitro (8) . The dramatic inhibitory effects of anti-IL-2-R antibody
on cell growth in thymic organ cultures (18) also suggest that, within an intact thymic
microenvironment, functional IL-2-R are important . The finding that overall cell
recovery ofthymocyteswas not affected by anti-IL-2-R treatment in vivo is not neces-
sarily at variance with the organ culture data in which anti-IL-2-R inhibited cell
growth (18) ; continued input of stem cells into the thymus and their subsequent ex-
pansion in vivo could overshadow inhibitory effects of anti-IL-2-R .
Since IL-2-R expression is confined to the CD4 -,CD8- subset (3-8), the observed
consequences of anti-IL-2-R antibody treatment in our study are most likely due
to effects on the CD4-,CD8 - subset only. These effects do not reflect elimination
or inhibition of generation of the majority of IL-2-R` cells, and occur despite the
low affinity of the IL-2-R on these cells . While our data do not formally exclude
an antiproliferative or cytotoxic effect of the treatment on a small subset of IL-
2-Rbearing cells, the block in maturation after anti-IL-2-R treatment is unequivocal .
Finally, although we favor an interpretation that places the important site of IL-
2-R expression and action on the thymocytes themselves, it must also be acknowledged
that some thymic nonlymphoid cells such as dendritic cells or macrophages could
express IL-2-R . Therefore, it is possible that the maturation arrest we observed in
thymocytes could result from the capacity of anti-IL-2-R antibody to block the produc-
tion of an unidentified thymocyte differentiation factor normally produced by an
IL-2-R-bearing accessory cell .
Summary
The role of the IL-2-IL-2-R pathway in thymocyte differentiation in vivo is un-
known . We have examined fetal thymocyte development in vivo, under conditions
where all IL-2-R were saturated from day 13 of gestation with anti-IL-2-R mAbs
that were previously shown to render matureT cells unable to respond to IL-2 . This
produced a dramatic change in the composition of developing T cells : thymocytes
from day 1 neonatal mice born to anti-IL-2-Rtreated mothers did not contain
CD4+ or CD8 + single-positive cell populations . In addition, no generation of sur-
faceTCR a chain-expressing T cells or antigen-reactive functional T cells occurred
in treated mice . These data suggest that IL-2-IL-2-R interactions provide signals
crucial to in vivo intrathymic development of mature T cells .
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